| 2.49 0.32 (14.75%) | 07-26 15:52 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term | |
|||
| Targets | 6-month : | 3.32  |
1-year : | 3.88 |
| Resists | First : | 2.84 |
Second : | 3.32 |
| Pivot price | 1.59 |
|||
| Supports | First : | 1.71 |
Second : | 1 |
| MAs | MA(5) : | 2.14 |
MA(20) : | 1.5 |
| MA(100) : | 3.41  |
MA(250) : | 6.09 |
|
| MACD | MACD : | 0.1 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 76.2 |
D(3) : | 74.2 |
| RSI | RSI(14): 68.8 |
|||
| 52-week | High : | 39.59 | Low : | 1 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.[ AONC ] has closed above the upper band by 3.6%. If price is in a uptrend band; this upward trend in price might continue. However a short term pullback inside the band is likely.Bollinger Bands are 24.5% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 2.85 - 2.86 | 2.86 - 2.87 |
| Low: | 2.08 - 2.09 | 2.09 - 2.1 |
| Close: | 2.47 - 2.49 | 2.49 - 2.51 |
American Oncology Network, Inc., through its subsidiaries, provides oncology services in the United States. The company provides various services to patients, including laboratory services for routine and specialized testing; in-house professional and technical pathology services with complete, accurate and timely pathology reports; in-house specialty pharmacy services with patient education, financial assistance, and 24/7 patient assistance; and care management support services including nutrition guidance. The company was incorporated in 2017 and is based in Fort Myers, Florida.
Fri, 26 Jul 2024
American Oncology Network (NASDAQ:AONC) Trading Down 1.8% - Defense World
Mon, 10 Jun 2024
American Oncology Network Announces the Commencement of OTCQX Trading - Yahoo Finance
Mon, 10 Jun 2024
OTC Markets Group Welcomes American Oncology Network, Inc. to OTCQX - Yahoo Finance
Mon, 03 Jun 2024
American Oncology Network Welcomes New CFO and COO - TipRanks
Tue, 21 May 2024
Gold Moves Lower; Macy's Boosts 2024 Forecast - Benzinga
Tue, 21 May 2024
American Oncology Network to delist its class A stock, warrants from Nasdaq (NASDAQ:AONC) - Seeking Alpha
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Care Facilities
|
|
| Shares Out | 10 (M) |
| Shares Float | 2 (M) |
| Held by Insiders | 41.5 (%) |
| Held by Institutions | 0.6 (%) |
| Shares Short | 11 (K) |
| Shares Short P.Month | 23 (K) |
| EPS | -1.77 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | -16.21 |
| Profit Margin | -0.9 % |
| Operating Margin | -5.2 % |
| Return on Assets (ttm) | -5.6 % |
| Return on Equity (ttm) | -102.1 % |
| Qtrly Rev. Growth | 20 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 131.24 |
| EBITDA (p.s.) | -2.43 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 27 (M) |
| Levered Free Cash Flow | 79 (M) |
| PE Ratio | -1.41 |
| PEG Ratio | 0 |
| Price to Book value | -0.16 |
| Price to Sales | 0.01 |
| Price to Cash Flow | 0.92 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|